Superiority of in vitro nondonor-specific immune monitoring over donor-specific assays in detecting a prerejection state.
Surg Forum, 1979;30:297-9.
Kirchoff C, McGeorge M, Thomas FT, Mendez-Picon G, Thomas JM, Lower RR, Lee HM
PMID: 120020
MeSH terms
Acute Disease; Antibody-Dependent Cell Cytotoxicity; Cost-Benefit Analysis; Cytotoxicity Tests, Immunologic; Graft Rejection; Heart Transplantation; Humans; Immunologic Techniques; Kidney Transplantation; T-Lymphocytes; Transplantation, Homologous
More resources
EndNote: Download